The influence of heroin abuse on glutathione-dependent enzymes in human brain.

00:18 EST 26th November 2014 | BioPortfolio

Summary of "The influence of heroin abuse on glutathione-dependent enzymes in human brain."

Heroin is an illicit narcotic abused by millions of people worldwide. In our earlier studies we have shown that heroin intoxication changes the antioxidant status in human brain. In the present work we continued our studies by estimating the effect of heroin abuse on reduced glutathione (GSH) and enzymes related to this cofactor, such as glutathione S-transferase detoxifying electrophilics (GST) and organic peroxides (as Se-independent glutathione peroxidase-GSHPx), and Se-dependent glutathione peroxidase (Se-GSHPx) specific mainly for hydrogen peroxide. Studies were conducted on human brains obtained from autopsy of 9 heroin abusers and 8 controls. The level of GSH and the activity of glutathione-related enzymes were determined spectrophotometrically. The expression of GST pi on mRNA and protein level was studied by RT-PCR and Western blotting, respectively. The results indicated significant increase of GST and GSHPx activities, unchanged Se-GSHPx activity, and decreased level of GSH in frontal, temporal, parietal and occipital cortex, brain stem, hippocampus, and white matter of heroin abusers. GST pi expression was increased on both mRNA and protein levels, however the increase was lower in brain stem than in other regions. Heroin affects all regions of human brain, and especially brain stem. Its intoxication leads to an increase of organic rather then inorganic peroxides in various brain regions. Glutathione S-transferase plays an important role during heroin intoxication, however its protective effect is lower in brain stem than in brain cortex or hippocampus.

Affiliation

Department of Biochemistry, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.

Journal Details

This article was published in the following journal.

Name: Drug and alcohol dependence
ISSN: 1879-0046
Pages:

Links

PubMed Articles [29700 Associated PubMed Articles listed on BioPortfolio]

A monoclonal antibody specific for 6-monoacetylmorphine (6-MAM) reduces acute heroin effects in mice.

Immunotherapy against drugs of abuse is being studied as an alternative treatment option in addiction medicine and is based on antibodies sequestering the drug in the bloodstream and blocking its entr...

Disruptive Behavior Disorders in 8 to 14 Years Old Offspring's of Opium and Heroin Dependent Parents: a Case-Control Study.

Drug abuse is usually associated with behavioral disorders in children especially conduct disorder. This study investigated the behavioral disorders of children whose parents were opium or heroin depe...

Comparison of internalizing disorders in 8-14-year-old offspring of opium and heroin dependent parents: a case-control study.

In general, parental substance abuse is associated with children's emotional and behavioral problems. This study only investigated the internalizing problems (depression, anxiety and physical complain...

Ameliorating activity of ginger (Zingiber officinale) extract against lead induced renal toxicity in male rats.

Lead poisoning has been known to be associated with structural and functional abnormalities of multiple organ systems of human body. The aim of this investigation was to study the renal protective eff...

The detection of codeine, morphine, 6-monoacetylmorphine, and meconin in human umbilical cord tissue: method validation and evidence of in utero heroin exposure.

Heroin abuse is a significant public health issue and is on the rise due to the unintended consequences of strengthening controls for non-medical use of prescription pain killers. Included in this tre...

Clinical Trials [5479 Associated Clinical Trials listed on BioPortfolio]

Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)

This research study takes place at Wayne State University and will take about 11 weeks to complete. This is a treatment research study for individuals who currently have cocaine abuse or d...

Testing the Effectiveness of Medications Used to Treat Heroin Dependence - 1

The number of new heroin users and problems associated with heroin use have increased steadily over the past several years. Currently, naltrexone is one of the drugs used to treat heroin ...

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5

The purpose of this study is to assess the abuse liability and reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent volunteers

Effects of Buspirone in Opiate Withdrawal

Dependence on heroin is a major public health problem because of its association with criminality, law enforcement costs and healthcare costs. Managed withdrawal is a required first step ...

Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens

Heroin dependence remains a major addiction problem in the United States. The purpose of this study is to determine the effectiveness of levoacetyl methadol (ORLAAM) in treating heroin de...

Medical and Biotech [MESH] Definitions

One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of glutathione from gamma-glutamylcysteine and glycine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.3.

Catalyzes the oxidation of GLUTATHIONE to GLUTATHIONE DISULFIDE in the presence of NADP+. Deficiency in the enzyme is associated with HEMOLYTIC ANEMIA. Formerly listed as EC 1.6.4.2.

An enzyme catalyzing the oxidation of 2 moles of glutathione in the presence of hydrogen peroxide to yield oxidized glutathione and water. EC 1.11.1.9.

Strong dependence, both physiological and emotional, upon heroin.

A glutathione transferase that catalyzes the conjugation of electrophilic substrates to GLUTATHIONE. This enzyme has been shown to provide cellular protection against redox-mediated damage by FREE RADICALS.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Alzheimer's Disease
Latest News Clinical Trials Research Drugs Reports Corporate
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Advertisement